Urol. praxi. 2017;18(1):22-25 | DOI: 10.36290/uro.2017.006

Metabolism and sex, sex and metabolism

MUDr. Michaela Šnejdrlová, Ph.D.
Centrum preventivní kardiologie, 3. interní klinika VFN a 1. LF UK, Praha

Erectile dysfunction is a relatively common health issue, with more than half of men aged 35–65 years in the Czech Republic

having a certain degree of the disease. The causes of erectile dysfunction can be psychogenic and organic, with the organic ones

including anatomical, neurogenic, hormonal, and vascular causes. Erectile dysfunction can be the first warning sign of serious

disease; therefore, one should not be content with symptomatic treatment only, but a patient with erectile dysfunction should

always undergo a comprehensive evaluation. This can result in improved prognosis as well as better quality of life.

Keywords: erectile dysfunction, atherosclerosis risk factors, dyslipidaemia, statins

Published: March 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šnejdrlová M. Metabolism and sex, sex and metabolism. Urol. praxi. 2017;18(1):22-25. doi: 10.36290/uro.2017.006.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Weiss P, Zvěřina J. Vliv věku a somatického zdraví na erektilní funkci mužů středního věku: výsledky reprezentativního výzkumu. Prakt. Lék. 2002; 82: 21-23.
    2. Metro MJ, Broderick GA. Diabetes and vascular impotence: does insulin dependence increase the relative severity? Int J Impot Res. 1999; 11(2): 87-89. Go to original source... Go to PubMed...
    3. Schachter M, et al. Erectile Dysfunction and Lipid Disorders. Current Medical Research and Opinion, 2000; 16(Suppl. 1): S9-12. Go to original source... Go to PubMed...
    4. Billups KL. Erectile dysfunction as an early sign of cardiovascular disease. International Journal of Impotence Research 2005; 17: 19-24. Go to original source... Go to PubMed...
    5. Hannan JL, Maio MT, Komolova M, et al. Beneficial impact of exercise and obesity interventions on erectile function and its risk factors. J Sex Med. 2009; 6(Suppl. 3): 254-261. Go to original source... Go to PubMed...
    6. Montorsi P, et al. The Artery Size Hypothesis: A Macrovascular Link Between Erectile Dysfunction and Coronary Artery Disease. Am J Cardiol, 2005; 96: 19M-23M. Go to original source... Go to PubMed...
    7. Kirby M, Jackson B, Simonsen U. Endothelial dysfunction links erectile dysfunction to heart disease. Int J Clin Pract, 2005; 59: 225-229. Go to original source... Go to PubMed...
    8. Schachter M. Erectile Dysfunction and Lipid Disorders. Current Medical Research and Opinion; 2000: 16. Go to original source... Go to PubMed...
    9. Billups KL. Erectile dysfunction as an early sign of cardiovascular disease. Int J Impot Res, 2005 Dec, 17 Suppl 1: S19-24. Go to original source... Go to PubMed...
    10. 2016 ESC/EAS Guidelines on the management of dyslipidaemias European Heart Journal 2016 - doi:10.1093/eurheartj/ehv272.
    11. Rosenbaum D, Dallongeville J, Sabouret P, et al. Discontinuation of statin therapy due to muscular side effects: a survey in real life. Nutr Metab Cardiovasc Dis. 2013; 23(9): 871-875. Go to original source... Go to PubMed...
    12. Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376: 1670-1681. Go to original source... Go to PubMed...
    13. McFarlane SI, Muniyappa R, Francisco R, et al. Clinical review 145: pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab. 2002; 87: 1451-1458. Go to original source... Go to PubMed...
    14. Tsunekawa T, Hayashi T, Kano H, et al. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation. 2001; 104: 376-379. Go to original source... Go to PubMed...
    15. Masumoto A, Hirooka Y, Hironaga K, et al. Effect of pravastatin on endothelial function in patients with coronary artery disease (cholesterol-independent effect of pravastatin) Am J Cardiol.2001; 88: 1291-1294. Go to original source... Go to PubMed...
    16. Corona G, Boddi V, Balercia G, et al. The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction. J Sex Med. 2010; 7: 1547-1556. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.